Product features:

Hyaluron Benefit Cream

Klotz Labs Hyaluron Benefit Creme offers particularly good tolerance and excellent skin care properties. This ideal day and night care cream provides the skin with high-quality lipids such as shea butter and squalane. In addition, the added hyaluron fragments keep the skin moisturised throughout the day. This ensures fewer wrinkles and firmer skin - visibly and noticeably. Hyaluron Benefit Cream is ideal for keeping a previously applied serum, such as Hyaluron Booster Serum, on the skin. The hyaluronic acid fragments added to the hyaluronic acid cream penetrate into deeper skin layers and intensively moisturise them. In addition, these fragments stimulate metabolic processes that promote a build-up of the skin's own support systems, reduce wrinkles and firm. Redness is reduced.

The hyaluron precursor N-acetylglucosamine and the skin's own lipids have anti-inflammatory properties. Redness is reduced, the skin is soothed and has a more even complexion. Thanks to special absorption substances, the light hyaluronic acid cream is absorbed particularly quickly and well. The skin feels smooth and retains its moisture throughout the day. Due to the absence of alcohol, parabens and fragrances, we guarantee your skin absolute tolerance and no negative effects, even and especially with long-term use.

Application:
Hyaluron Benefit Cream is a day and night care cream that should be used daily. If you also use a high-dosage serum, such as Hyaluron Booster Serum, you should apply the cream after Hyaluron Booster Serum has been absorbed for about 1 - 2 minutes. So: Cleanse, Booster, Benefit! This additionally supports the effect of the serum.

Ingredients:
Aqua, Propylene Glycol, Caprylic/Capric Triglyceride, Cetearyl Olivate, Sorbitan Olivate, Squalane, Tocopheryl Acetate, Glycerin, Butyrospermum Parkii Butter, Urea, Sodium Hyaluronate, Niacinamide, Xanthan Gum, Acetyl Glucosamine, Calcium Pantothenate, Sodium Citrate, Adenosine, Citric Acid, Ceramide NP.

Source: www.klotz-labs.com
Status: 04/2022.